Quadrille Capital
Quadrille Capital is an independent global tech and healthcare investment firm founded in 2001 as the venture-capital arm of the Quilvest family office (mgmt-co created 2007, AMF GP07000013 SIREN 495392458). In 2012 founding partners Jerome Chevalier and Henri de Perignon led a spin-off from Quilvest to create Quadrille Capital as an independent SAS headquartered at 16 place de la Madeleine 75008 Paris with offices in San Francisco and New York. The firm manages around EUR 1.6 billion across four complementary strategies (growth equity directs + primary VC fund commitments + secondary LP and GP transactions + an evergreen public-equity UCITS vehicle). 40+ professionals invest globally across enterprise software consumer internet fintech and digital health. Notable holdings BlaBlaCar Rohlik Group ezCater Homa PlanRadar Hivebrite Sanas Wisetack BigHat Biosciences. Confirmed realized exits Freshly 2020 Nestle USA up to USD 1.5bn + Expanse 2020 Palo Alto Networks USD 800M + Tuya 2021 NYSE IPO USD 11.75bn + Bitglass 2021 Forcepoint + Onna 2024 Reveal Data + Hinge Health 2025 NYSE IPO + Ollie 2024 Agrolimen.
Key facts
Recent exits
Coverage notes
3 funds tracked, 27 portfolio companies (20 active · 7 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Quadrille Capital has raised, with its portfolio companies. Hand-checked from public filings.
Quadrille Technologies VGrowth2025 · 1yr€285M4 active
Unrealized
4 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Adonis | Healthcare | US | 2026 |
| GitGuardian | Software | France | 2026 |
| Qida | Healthcare | Spain | 2025 |
| Reco | Software | US | 2026 |
Quadrille Technologies IVVC2021 · 5yr€511M14 active · 2 realized
Unrealized
14 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Anyfin | Financials | Sweden | 2021 |
| BigHat Biosciences | Healthcare | US | 2022 |
| Evy | Financials | France | 2022 |
| Exoticca | Consumer | Spain | 2024 |
| Hivebrite | Software | France | 2023 |
| Homa | Software | France | 2022 |
| JobAndTalent | Software | Spain | 2019 |
| Medwing | Healthcare | Germany | 2023 |
| NA-KD | Consumer | Sweden | 2019 |
| PlanRadar | Software | Austria | 2022 |
| Prose | Consumer | US | 2020 |
| Rohlik Group | Consumer | Czech Republic | 2021 |
| Sanas | Software | US | 2025 |
| Wisetack | Financials | US | 2024 |
Quadrille Technologies IIIVC2015 · 11yr€100M2 active · 5 realized
Unrealized
2 heldRealized
5 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Bitglass | Software | US | 2019 | 2021 | Trade Sale | – | |
| Expanse | Software | US | 2019 | 2020 | Trade Sale | – | |
| Freshly | Consumer | US | 2018 | 2020 | Trade Sale | – | |
| Hinge Health | Healthcare | US | 2020 | 2025 | IPO | – | |
| Tuya | Software | China | 2017 | 2021 | IPO | – |
Saved GPs appear in your watchlist, one click from your workspace.
About Quadrille Capital
Quadrille Capital is a French venture capital firm headquartered in Paris with capital deployed across 4 active fund vehicles. Founded in 2007, the firm deploys institutional capital across early-stage and selective growth-stage equity rounds in European technology companies, with sector focus spanning TMT and healthcare.
Investment thesis
Quadrille Capital targets European and selectively global early-stage and growth-stage technology companies across TMT and healthcare, deploying institutional venture capital across seed, Series A and Series B rounds. The firm emphasises hands-on operational support during the post-investment value-creation phase, leveraging founder and operator partners alongside institutional capital to support international expansion and category leadership across France and selectively across Europe. Average equity tickets vary by stage with reserve capital preserved for follow-on rounds across the platform.
Recent activity
Realised exits across the current platform vintages remain limited, with the portfolio in active deployment and value-creation phase. The platform tracks 4 fund vehicles, 23 active portfolio companies and 0 realised exits across the strategy's history. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.
France·€196.0BFrance·€52.8BFrance·€33.0BFrance·€27.0BFrance·€13.2BFrance·€11.6BFrance·€9.0BFrance·€7.0BFrance·€6.7BFrance·€4.3BFrance·€4.0BFrance·€4.0B